MyFinsight
Home
Blog
About
Contact
Download
Download image
Prescription Transactions
Revenue
$544,001K
Pharma Direct Revenue
$151,380K
Subscription Revenue
$83,786K
Other Revenue
$17,686K
Revenue
$796,853K
(0.57%↑ Y/Y)
Operating income (loss)
$87,492K
(32.87%↑ Y/Y)
Total costs and
operating expenses
$709,361K
(-2.36%↓ Y/Y)
Income (loss) before
income taxes
$56,538K
(79.71%↑ Y/Y)
Total other expense,
net
-$30,954K
(9.98%↑ Y/Y)
Interest income
$10,933K
(-53.02%↓ Y/Y)
Other income
(expense)
$718K
(126.99%↑ Y/Y)
Sales and marketing
$331,560K
(-9.68%↓ Y/Y)
Product development and
technology
$121,026K
(-2.20%↓ Y/Y)
General and
administrative
$113,960K
(-3.31%↓ Y/Y)
Depreciation and
amortization
$85,218K
(22.55%↑ Y/Y)
Cost of revenue,
exclusive of depreciation...
$57,597K
(19.46%↑ Y/Y)
Net income (loss)
$30,439K
(85.72%↑ Y/Y)
Income tax (expense)
benefit
$26,099K
(73.19%↑ Y/Y)
Interest expense
$42,605K
(-19.49%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)